Theramyt Novobiologics
Bengaluru
About Theramyt Novobiologics
Theramyt is a unique bio-enterprise building tomorrow’s biologics – biobetters. We apply our drug designing and platform technology strengths to deliver novel therapies for disease areas such as oncology, rheumatoid arthritis, diabetes and metabolic disorders.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2013)
- Website: theramyt.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Diabetes, Enterprise, Oncology
Canonical: https://fsome.com/organization/theramyt-novobiologics-3694431 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.